President Donald Trump announced two new policies aimed at improving access to in-vitro fertilization (IVF). The first policy is focused on lowering the cost of a key fertility drug. This is a significant development, as the high cost of fertility drugs is often a barrier to many people seeking IVF treatment. The second policy encourages employers to expand fertility benefits, which could potentially make IVF more accessible to a larger number of people. It is important to note, however, that these policies do not include any new funding or coverage mandates.